Two Treatment Regimens of Cocamide DEA Lotion for Head Lice

• Status: Terminated
• Trial end date: 1999-12-01
• Target enrollment: 0
• Participant gender: All

Summary

To assess the efficacy and safety of 10% Cocamide DEA using two treatment regimens in the eradication of head lice. To assess the ability of each treatment regimen to kill all viable ova and to assess patient acceptability of the product in use

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Medical Entomology Centre
• Collaborator: Riemann a/s

Criteria

Inclusion Criteria:

• Male and female patients over the age of 4 who are found to have a head louse infection.

• Patients who give written informed consent and, if the patient is under 16 years of age, whose guardian gives written informed consent to participate in the study.

• Available for the duration of study i.e. 15 days.

Exclusion Criteria:

• Patients with a known sensitivity to paraben preservatives.

• Patients who have been treated with other head lice products within the last 2 weeks.

• Patients who have undergone a course of antibiotic treatment within the last 4 weeks.

• Patients who have any persistent skin disorder of the scalp (i.e. eczema, chronic dermatitis, psoriasis).

• Patients whose hair has been bleached, colour treated or permed within the last 4 weeks.

• Patients who have participated in another clinical trial within 1 month prior to entry to this study.

• Patients who have already participated in this clinical trial.